Entera Bio Ltd. – Filings and Transcripts

NASDAQ: ENTX
Share price (9/4/26): $3.00
Market cap (9/4/26): $522 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Prospectus supplement

Ownership Filter

Camisasca Riccardo Paolo

News Filter

Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

Announces Second Quarter 2026 Financial Results and Business Updates

Material Definitive Agreement, Unregistered Sales of Equity Securities, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC